Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

MRSNMRSN
30 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in MERSANA THERAPEUTICS INC

BNP PARIBAS FINANCIAL MARKETS previously held 0 shares of MRSN (MERSANA THERAPEUTICS INC), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$1,155

Total Shares Change

-283

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$29.08
0
2025-Q4
Increased
1,090
+105.3%
$31,5340.0%$28.65
22
2025-Q3
Decreased
531
-80.8%
$4,1210.0%$7.79
0
2025-Q2
Decreased
2,765
-98.6%
$8180.0%$7.28
0
2025-Q1
Decreased
201,448
-44.2%
$69,3380.0%$9.49
0
2024-Q4
Increased
361,147
+52.3%
$516,4400.0%$35.50
34
2024-Q3
Decreased
237,198
-29.4%
$448,3040.0%$46.25
0
2024-Q2
Increased
336,079
+316.3%
$675,5190.0%$50.25
40
2024-Q1
Increased
80,735
+90.0%
$361,6930.0%$112.00
37
2023-Q4
Decreased
42,496
-65.5%
$98,5910.0%$58.00
0
2023-Q3
Increased
123,345
+66.7%
$156,6480.0%$31.75
33
2023-Q2
Decreased
74,002
-66.6%
$243,4670.0%$80.00
0
2023-Q1
Increased
221,708
+80.7%
$911,2200.0%$100.00
38
2022-Q4
Decreased
122,676
-48.4%
$718,8810.0%$146.50
0
2022-Q3
Decreased
237,665
-56.0%
$1.6M0.0%$160.50
0
2022-Q2
Decreased
539,703
-17.3%
$2.5M0.0%$111.25
0
2022-Q1
Increased
652,613
+5.5%
$2.6M0.0%$100.50
28
2021-Q4
Increased
618,416
+761.5%
$3.8M0.0%$160.00
43
2021-Q3
Increased
71,780
+2771.2%
$676.9M0.0%$233.25
51
2021-Q2
Decreased
2,500
-64.0%
$33,9500.0%$332.00
0
2021-Q1
Increased
6,946
+5.8%
$112,3860.0%$382.75
23
2020-Q4
Decreased
6,568
-48.4%
$174,7740.0%$664.50
0
2020-Q3
Increased
12,718
+225.9%
$236,8090.0%$469.50
37
2020-Q2
Decreased
3,902
-64.9%
$91,3070.0%$557.00
0
2020-Q1
Increased
11,120
+28.6%
$64,8300.0%$164.00
26
2019-Q4
Increased
8,648
+169.5%
$49,5530.0%$130.38
33
2019-Q3
Increased
3,209
+2.2%
$5,0700.0%$39.50
10
2019-Q2
Increased
3,140
+17.4%
$12,7170.0%$101.25
14
2019-Q1
Increased
2,674
+844.9%
$14,0650.0%$131.50
20
2018-Q4
New
283
-
$1,1550.0%$101.25
17

Other major holders of MRSN: Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used